{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:32:09Z","timestamp":1791909129720,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.pathol.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T17:27:03Z","timestamp":1632158823000},"page":"308-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elysse","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandya","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Vong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0031-1281028","article-title":"von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder","volume":"37","author":"Favaloro","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thromres.2014.05.020","article-title":"Evaluating errors in the laboratory identification of von Willebrand disease in the real world","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2021.07.001_bib3","first-page":"17","article-title":"von Willebrand factor: form for function","volume":"40","author":"Yee","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 2","key":"10.1016\/j.pathol.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"s17","DOI":"10.1016\/S0049-3848(10)70149-3","article-title":"Rethinking the diagnosis of von Willebrand disease","volume":"127","author":"Favaloro","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bod\u00f3","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-0040-1713735","article-title":"Navigating the myriad of von Willebrand factor assays","volume":"40","author":"Favaloro","year":"2020","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.pathol.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-1-4939-7196-1_33","article-title":"Laboratory testing for von Willebrand factor activity by glycoprotein Ib binding assays (VWF:GPIb)","volume":"1646","author":"Patzke","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pathol.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the zimmerman program for the molecular and clinical biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14712598.2012.667398","article-title":"Biological therapies for von Willebrand disease","volume":"12","author":"Favaloro","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.pathol.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom haemophilia centre doctors organization guideline approved by the British committee for standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.07.001_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-1-4939-7196-1_31","article-title":"Laboratory testing for von Willebrand factor collagen binding (VWF:CB)","volume":"1646","author":"Favaloro","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pathol.2021.07.001_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.thromres.2015.12.010","article-title":"Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease","volume":"141","author":"Favaloro","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2021.07.001_bib16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2011.04460.x","article-title":"Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay","volume":"9","author":"Chen","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12064","article-title":"A\u00a0comparative evaluation of a new automated assay for von Willebrand factor activity","volume":"19","author":"Lawrie","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-1-4939-7196-1_34","article-title":"Laboratory testing for von Willebrand factor: factor VIII binding (for 2N VWD)","volume":"1646","author":"Mohammed","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pathol.2021.07.001_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/hae.13957","article-title":"Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies","volume":"26","author":"Favaloro","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-0037-1614375","article-title":"Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey","volume":"82","author":"Favaloro","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00001721-200012000-00006","article-title":"Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey","volume":"11","author":"Favaloro","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.pathol.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1309\/8WVANM7H0DKTGB9F","article-title":"Laboratory diagnosis of von Willebrand disorder: current practice in the Southern Hemisphere","volume":"119","author":"Favaloro","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2516.2004.00897.x","article-title":"Laboratory diagnosis of von Willebrand Disorder: quality and diagnostic improvements driven by peer review in a multi-laboratory test process","volume":"10","author":"Favaloro","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1532\/LH96.04063","article-title":"Laboratory diagnosis of von Willebrand Disorder: use of multiple functional assays reduces diagnostic error rates","volume":"11","author":"Favaloro","year":"2005","journal-title":"Lab Hematol"},{"key":"10.1016\/j.pathol.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2006-947865","article-title":"Reducing errors in identification of von Willebrand disease: the experience of the royal College of Pathologists of Australasia quality assurance program","volume":"32","author":"Favaloro","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1160\/TH06-12-0693","article-title":"2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of Type 2B VWD","volume":"98","author":"Favaloro","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/hae.12903","article-title":"Type 2M von Willebrand disease \u2013 more often misidentified than correctly identified","volume":"22","author":"Favaloro","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jth.14145","article-title":"A\u00a0comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients","volume":"16","author":"Vangenechten","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.pathol.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH14-02-0108","article-title":"Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance","volume":"112","author":"de Maistre","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijlh.12218","article-title":"Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin","volume":"36","author":"Graf","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2021.07.001_bib32","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.thromres.2014.09.024","article-title":"Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2021.07.001_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2018.04.015","article-title":"Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: a large international cross-laboratory study","volume":"166","author":"Favaloro","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2021.07.001_bib34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1160\/TH10-06-0360","article-title":"Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease","volume":"104","author":"Favaloro","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2021.07.001_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hae.14204","article-title":"How we diagnose 2M von Willebrand disease (VWD): use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types","volume":"27","author":"Favaloro","year":"2021","journal-title":"Haemophilia"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521004335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521004335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:13:51Z","timestamp":1648595631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521004335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0031302521004335"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.07.001","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}